Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 3Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 2

Conditions

Urologic Neoplasms 2Urinary Bladder Neoplasms 1Post-operative Residual Curarization 1

Interventions

Dexamethasone 49Metformin 47Cyclophosphamide 42Saline Solution 38Cytarabine 34Sodium Chloride 32Bupivacaine 31Vincristine 27Cisplatin 26Propofol 25Methotrexate 25Letrozole 24Fluorouracil 24Dexmedetomidine 24Doxorubicin 23Fentanyl 22Carboplatin 22Etoposide 19Rituximab 18Morphine 18Bevacizumab 18Acetaminophen 18Lidocaine 17Granulocyte Colony-Stimulating Factor 17Prednisone 16Mercaptopurine 16Docetaxel 16Clomiphene 16Sevoflurane 15Ropivacaine 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × OTHER × Neostigmine × Clear all
NCT03210376 2020-11-25

Neuromuscular Blockade on Shoulder Pain of Elderly

M.D. Anderson Cancer Center

Phase 4 Completed
100 enrolled 17 charts
Genitourinary

Urologic Neoplasms

NCT03138967 2020-09-22

Investigation of Sugammadex in Outpatient Urological Procedures

M.D. Anderson Cancer Center

Phase 4 Completed
54 enrolled 12 charts
Genitourinary

Urinary Bladder Neoplasms, Urologic Neoplasms

NCT03996655 2019-06-25

Different Reversal Agents in Pediatric Day-case Cancer Surgery

National Cancer Institute, Egypt

Phase 4 Unknown
80 enrolled

Post-operative Residual Curarization

Data powered by HemOnc (CC BY 4.0) Colophon âš¡